World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
135
Citations
92886
World Ranking
2021
National Ranking
1147

Overview

Michael J. Birrer is affiliated with the University of Arkansas for Medical Sciences in the United States. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology, with significant contributions particularly in oncology.

Their recent publications include several papers focused on cancer and proteogenomics. Notable works include:

  • Pan-cancer analysis of whole genomes, 2020, Nature
  • Proteogenomic and metabolomic characterization of human glioblastoma, 2021, Cancer Cell
  • Proteogenomic characterization of pancreatic ductal adenocarcinoma, 2021, Cell
  • Proteogenomic Characterization of Endometrial Carcinoma, 2020, Cell
  • Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma, 2021, Cancer Cell

The primary fields of study in Birrer's research are:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, their work focuses on specific subfields, including:

  • Oncology
  • Molecular Biology
  • Reproductive Medicine
  • Immunology
  • Cancer Research

Main research topics associated with their publications include:

  • Ovarian cancer diagnosis and treatment
  • Cancer Genomics and Diagnostics
  • PARP inhibition in cancer therapy
  • Cancer Immunotherapy and Biomarkers
  • Endometrial and Cervical Cancer Treatments
  • Immune cells in cancer
  • Ferroptosis and cancer prognosis

Michael J. Birrer has collaborated frequently with several researchers, including:

  • Ursula A. Matulonis
  • Heather A. Lankes
  • David M. O'Malley
  • Li Ding
  • Kathleen N. Moore

Common venues for their publications reflect a focus on oncology and related biomedical sciences, featuring a recurring presence in:

  • Gynecologic Oncology
  • Journal of Clinical Oncology
  • Cell
  • UNC Libraries
  • Annals of Oncology

Best Publications

  • Integrated genomic analyses of ovarian carcinoma

    D. Bell;A. Berchuck;M. Birrer;J. Chien

  • Integrated genomic characterization of endometrial carcinoma

    Gad Getz;Stacey B. Gabriel;Kristian Cibulskis;Eric Lander

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Incorporation of bevacizumab in the primary treatment of ovarian cancer

    Robert A. Burger;Mark F. Brady;Michael A. Bookman;Gini F. Fleming

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • p53: a frequent target for genetic abnormalities in lung cancer

    Takashi Takahashi;Marion M. Nau;Itsuo Chiba;Michael J. Birrer

  • Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

    Robert L Coleman;Amit M Oza;Domenica Lorusso;Carol Aghajanian

  • Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer

    David D. Bowtell;David D. Bowtell;Steffen Böhm;Ahmed A. Ahmed;Paul Joseph Aspuria

  • BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

    Kathryn Alsop;Sian Fereday;Cliff Meldrum;Anna deFazio

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

    Adam Abeshouse;Clement Adebamowo;Sally N. Adebamowo;Rehan Akbani

  • Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

    Tod Smeal;Bernard Binetruy;Bernard Binetruy;Daniel A. Mercola;Michael Birrer

  • Dicer, Drosha, and outcomes in patients with ovarian cancer

    William M. Merritt;Yvonne G. Lin;Liz Y. Han;Aparna A. Kamat

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Inherited Mutations in Women With Ovarian Carcinoma

    Barbara M. Norquist;Maria I. Harrell;Mark F. Brady;Tom Walsh

  • Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

    Lin Zhang;Stefano Volinia;Tomas Bonome;George Adrian Calin

  • Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

    Roel G.W. Verhaak;Pablo Tamayo;Ji Yeon Yang;Diana Hubbard

  • Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

    Joyce F. Liu;William T. Barry;Michael Birrer;Jung Min Lee

  • Integrated genomic analyses of ovarian carcinoma

    D. Bell;A. Berchuck;M. Birrer;J. Chien

Frequent Co-Authors

Samuel C. Mok
Samuel C. Mok The University of Texas MD Anderson Cancer Center
Ursula A. Matulonis
Ursula A. Matulonis Harvard University
Kathleen N. Moore
Kathleen N. Moore University of Oklahoma Health Sciences Center
Robert S. Mannel
Robert S. Mannel University of Oklahoma Health Sciences Center
David M. O'Malley
David M. O'Malley The Ohio State University
Wei Wei
Wei Wei University of Technology Sydney
Anil K. Sood
Anil K. Sood The University of Texas MD Anderson Cancer Center
Gini F. Fleming
Gini F. Fleming University of Chicago
Andrew Berchuck
Andrew Berchuck Duke University
Douglas A. Levine
Douglas A. Levine New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers that don't always require a traditional medical degree, several rewarding options exist. Advancements in technology and flexible learning make it easier than ever to pursue these pathways through online programs.

One fast-growing field is pharmacy, and many students are turning to online pharmacist degree programs for flexibility and affordability. Another option is working with medical records and health data, and accredited him programs can open doors in this high-demand sector.

Medical coding is essential for healthcare operations, and those interested in this specialty often look for information on medical coding certification cost to help decide on the right program. For nurses aiming to advance their careers, there are most affordable online nurse practitioner programs that deliver career growth while supporting a flexible learning schedule.

Exploring these online degree options allows for diverse roles within healthcare, offering accessible pathways to a variety of dynamic and meaningful careers.

Best Scientists Citing Michael J. Birrer

Trending Scientists